BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2957965)

  • 1. Plasmin induces acantholysis in skin organ cultures.
    Hunziker T; Vassalli JD
    Arch Dermatol Res; 1987; 279(5):341-6. PubMed ID: 2957965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An organ culture model for the study of pemphigus acantholysis.
    Michel B; Ko CS
    Br J Dermatol; 1977 Mar; 96(3):295-302. PubMed ID: 322692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T; Besch R; Braungart E; Flaig MJ; Douwes K; Sander CA; Magdolen V; Probst C; Wosikowski K; Degitz K
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.
    Schiltz JR; Michel B
    J Invest Dermatol; 1976 Aug; 67(2):254-60. PubMed ID: 950490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis.
    Morioka S; Naito K; Ogawa H
    J Invest Dermatol; 1981 May; 76(5):337-41. PubMed ID: 7014725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W; Hashimoto K; Toi Y
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z; Liu R; Ye Q
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus acantholysis in tissue culture: studies on photo-induction.
    Gschnait F; Pehamberger H; Holubar K
    Acta Derm Venereol; 1978; 58(3):237-9. PubMed ID: 78638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis.
    Naito K; Morioka S; Nakajima S; Ogawa H
    J Invest Dermatol; 1989 Jul; 93(1):173-7. PubMed ID: 2526184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appearance of "pemphigus acantholysis factor" in human skin cultured with pemphigus antibody.
    Schiltz JR; Michel B; Papay R
    J Invest Dermatol; 1979 Dec; 73(6):575-81. PubMed ID: 512411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus IgG induces expression of urokinase plasminogen activator receptor on the cell surface of cultured keratinocytes.
    Seishima M; Satoh S; Nojiri M; Osada K; Kitajima Y
    J Invest Dermatol; 1997 Nov; 109(5):650-5. PubMed ID: 9347794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
    Anhalt GJ; Patel HP; Labib RS; Diaz LA; Proud D
    J Immunol; 1986 Jan; 136(1):113-7. PubMed ID: 3079604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K; Wun TC; Baird J; Lazarus GS; Jensen PJ
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of plasminogen activator in pemphigus vulgaris.
    Wilkinson JE; Smith CA; Suter MM; Falchek W; Lewis RM
    Am J Pathol; 1989 Mar; 134(3):561-9. PubMed ID: 2466403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid, retinoid, and protease inhibitors on the formation of acantholysis induced in organ culture of skins from patients with benign familial chronic pemphigus.
    Ikeda S; Ogawa H
    J Invest Dermatol; 1991 Oct; 97(4):644-8. PubMed ID: 1940435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW; Geoghegan WD; Jordon RE
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylprednisolone inhibits pemphigus acantholysis in skin cultures.
    Swanson DL; Dahl MV
    J Invest Dermatol; 1983 Sep; 81(3):258-60. PubMed ID: 6886473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.
    Hunziker T; Nydegger UE; Lerch PG; Vassalli JD
    Clin Exp Immunol; 1986 May; 64(2):442-9. PubMed ID: 3742881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.